Ginkgo Bioworks Holdings (DNA)Director sold ~$109K

~$109K

Approx. value · 10K sh @ $10.92

34K

Holds after · shares reported

Traded

Sep 8, 2025

Filed

Sep 10, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jul 17, 2025InsiderOfficer sold ~$11K of DNA shares in the open market
2. Aug 22, 2025InsiderOfficer sold ~$3.8K of DNA shares in the open market
3. Sep 8, 2025 · this disclosureInsiderDirector sold ~$109K of DNA shares in the open market

What came next

1. Sep 9, 2025InsiderDirector sold ~$111K of DNA shares in the open market
2. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
3. Dec 18, 2025Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On December 18, 2025, Ginkgo Bioworks Holdings, Inc. (the “Company”) announced that Dr. Reshma Shetty, the Company’s President, Chief Operating Officer, and member of the Board of Directors, will transition her Chief Operating Officer duties to Jennifer Wipf and Dr. Jason Kelly, the Company’s Chief Executive Officer, on January 1, 2026.”

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Ginkgo Bioworks Holdings

For Ginkgo Bioworks Holdings, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DNA page.

Other recent filings by Christian O Henry, Director

• SEC Form 4 at Ginkgo Bioworks Holdings (DNA)Sep 10, 2025
• SEC Form 4 at Wave Life Sciences (WVE)Aug 14, 2025
• SEC Form 4 at Wave Life Sciences (WVE)Mar 22, 2025
• SEC Form 4 at Pacific Biosciences Of California (PACB)Mar 5, 2025
• SEC Form 4 at Pacific Biosciences Of California (PACB)Feb 19, 2025

The full history of Christian O Henry, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Ginkgo Bioworks Holdings

• SEC Form 4Oct 7, 2026
• SEC Form 144Oct 5, 2026
• USAspending.gov award recordAug 5, 2026
• SEC Form 13F-HRFeb 11, 2026
• SEC Form 13F-HRNov 12, 2025
• SEC Form 4Sep 10, 2025

Everything OQRO holds on this company is on its DNA page.